to be used starting at age 12.Moderna aims to be next in line, saying it will submit its teen data to the U.S. Food and Drug Administration and other global regulators early next month.The company studied more than 3,700 12- to 17-year-olds.
Preliminary findings showed the vaccine triggered the same signs of immune protection in kids as it does in adults, and the same kind of temporary side effects such as sore arms, headache and fatigue.A person receives a COVID-19 vaccination at a vaccination clinic on May 12, 2021, in Milford, Pennsylvania. (Photo by Preston Ehrler/SOPA Images/LightRocket via Getty Images) There were no COVID-19 diagnoses in those given two doses of the Moderna vaccine compared with four cases among kids given dummy.